Most interestingly, a role for PNPLA3 emerged as a key independent risk factor for weight gain, opening new perspectives in the risk stratification and follow-up of NAFLD patients, especially in patients who could not regularly attend the hepatology clinic. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.